Lobbying

Degrees of Dependency: Drug Companies & Patient Groups

In a survey of 29 U.S. patient groups, New Scientist found only two ruled out drug company funding. Seven of the patient groups surveyed received less than 5% of their income from drug companies, while others were reliant on them for over one-third of their budget.

No

European Brewers Aim to Derail Alcohol Strategy

The European Commission "may be the victim of a carefully planned attack by representatives of the alcohol industry" to derail the adoption of a strategy to reduce the health effects of alcohol, warns Martin McKee, professor of European public health from the London School of Hygiene and Tropical Medicine.

No

Ex-FDA Commissioner Turned Lobbyist Pleads Guilty

The former commissioner of the U.S. Food and Drug Administration (FDA), Lester Crawford, has pleaded guilty to breaching conflict of interest rules. Crawford and his wife held between $188,000 and $336,000 in shares in four companies that he was required to have sold, under FDA rules.

No

Nuclear Industry Offers Nevada Hush Money

Image from an NEI ad"We all knew it would come to this, didn't we?" a Las Vegas Review-Journal editorial asks, of a new offer by the Nuclear Energy Institute (NEI) to pay Nevada to accept nuclear waste at the controversial Yucca Mountain storage facility.

No

If We Stop Using Highly Toxic Chemicals, the Terrorists Will Have Won

"An analysis by the Department of Homeland Security found 272 chemical plants nationwide at which an attack or accident could affect at least 50,000 people and an additional 3,400 plants at which more than 1,000 people were at risk," reports the New York Times.

No

The Year of Lobbying Dangerously

"Indonesia's national intelligence agency used a former Indonesian president's charitable foundation to hire a Washington lobbying firm ... to press the U.S. government for a full resumption of controversial military training programs," reports the Center for Public Integrity's International Consortium of Investigative Journalists.

No

Pages

Subscribe to Lobbying